Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 451 of 6351
-
New radioactive 'Theranostic' drugs aim to find and treat brain tumors
Disease control Not yet recruitingThis trial will evaluate treatment for patients with solid tumors with active brain metastases. Patients will be treated with a theranostic or diagnostic agent. Theranostic agents are targeted radioactive drugs used to identify (diagnose) and to deliver therapy. The main purpose …
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo aims to beat standard CLL therapy in older patients
Disease control Recruiting nowThis phase III trial compares the effect of adding sonrotoclax to zanubrutinib versus zanubrutinib alone for the treatment of patients with untreated chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL). Sonrotoclax is in a class of medications called B-cell lymp…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for stomach cancer: drug combo aims to outperform chemo
Disease control Recruiting nowThis is a phase III, Multicenter, Randomized study, evaluating the efficacy and Safety of LM-108(an Anti-CCR8 mAb) in combination With Toripalimab Versus Paclitaxel Injection in subjects with CCR8-Positive locally advanced or metastatic Gastric Cancer and Gastroesophageal Junctio…
Phase 3 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New HPV vaccine trial aims to protect kids and teens from cancer
Vaccine Recruiting nowThis is a randomized observer-blind placebo-controlled proof-of-concept study with the aim to assess the safety and tolerability, and the immunogenicity of a bivalent HPV vaccine administered in healthy infants and toddlers (9- and 15-month-olds) comparing them to an immune-bridg…
Phase 2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo shows promise for tough esophageal cancer
Disease control Recruiting nowThis study will test a new potential treatment for advanced esophageal squamous cell cancer (ESCC) for patients whose initial treatment has stopped working. Currently, the standard second-line treatment for this cancer is PD-1 inhibitors or chemotherapy alone, which is not very e…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New study aims to spare breast cancer patients from chemo and major surgery
Disease control Not yet recruitingThis is a pragmatic phase 2 study to determine the proportion of patients with ER+ (≥10%)/HER2- EBC in whom neoadjuvant chemotherapy can be replaced by NET plus abemaciclib based on the results of the ODX RS obtained in the initial diagnostic biopsy and according to the MDT decis…
Phase 2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Engineered immune cells take on hard-to-treat lymphoma in early trial
Disease control Recruiting nowTo evaluate the safety and tolerability of GB5005 in patients with CD19-positive relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL).
Phase 1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug duo targets hard-to-treat lung cancer in early trial
Disease control Not yet recruitingThis is a phase II, open-label, single-arm study evaluating the efficacy and safety of SHR-A1811 (a HER2-targeted ADC) combined with AK112 (a PD-1/VEGF bispecific antibody) in patients with HER2-amplified or overexpressed locally advanced or metastatic NSCLC.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for pancreatic cancer: experimental drug combo enters large trial
Disease control Recruiting nowCancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The pancreas is a gland behind the stomach that produces a digestive fluid that is emptied into the intestines through tube shaped ducts. Pancreatic cancer often starts in these du…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for elderly lymphoma patients: targeted combo aims to control aggressive cancer
Disease control Recruiting nowEfficacy and safety of chidamide in combination with the R-mini CHOP regimen, followed by chidamide plus CD20 monoclonal antibody as maintenance therapy, in elderly patients with newly diagnosed MYC/BCL2 double-expressor DLBCL.
Phase 2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New clip surgery could help diabetics with lower weight
Disease control Recruiting nowThis study evaluates a new surgical device - the Metallic Anastomotic Clip (MAC) - for performing a laparoscopic bypass gastroenteroanastomosis with entero-enteric anastomosis (transit bipartition / "dual-path" procedure) in patients with type 2 diabetes mellitus (T2DM) who have …
Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Smart insulin pump aims to simplify diabetes management
Disease control Recruiting nowA multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, with the primary endpoint after 15 weeks and sec…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Drug cocktail before surgery may cut liver cancer recurrence
Disease control Not yet recruitingPostoperative recurrence remains a major limitation to long-term survival in hepatocellular carcinoma (HCC). In addition, a narrow surgical margin is widely regarded as a risk factor for recurrence. Neoadjuvant therapy may represent a strategy to reduce the risk of recurrence, th…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a simple gas during heart surgery protect your kidneys?
Prevention Not yet recruitingThe goal of this clinical trial is to learn if giving inhaled nitric oxide during heart surgery can prevent acute kidney injury (AKI) in patients who are at high risk of developing this complication. AKI is a serious problem after heart surgery and can lead to longer hospital sta…
Sponsor: Shanghai Zhongshan Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Herbal mouthwash may stop radiation mouth sores before they start
Prevention Not yet recruitingThis is a multicenter, randomized, controlled, prospective clinical trial designed to observe and evaluate the safety and efficacy of Modified Dahuang Huanglian Xiexin Mouthwash for the prevention of radiotherapy-induced oral mucositis (RTOM). Participants will be randomly assig…
Phase 3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Could stem cells and a special diet ease autism symptoms? new trial aims to find out.
Disease control By invitation onlyAutism spectrum disorder (ASD) is a neurodevelopmental condition with core deficits in social communication and behavior, often accompanied by gastrointestinal (GI) and metabolic dysfunction. Emerging evidence supports the role of neuroinflammation (including autoimmune component…
Phase 1/2 • Sponsor: Black Tie Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New transplant combo aims to outsmart relapsed leukemia
Disease control Not yet recruitingThis is a prospective, single-center, observational study to evaluate the efficacy and safety of salvage haploidentical allogeneic hematopoietic stem cell transplantation (haplo-HSCT) combined with post-transplant relapse prevention strategies in patients with relapsed/refractory…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New adaptive radiation boosts rectal cancer response rates
Disease control Not yet recruitingThe aim of this clinical study is to increase the rate of pathological responses up to 70% by means of improved patient selection operated by a radiobiological index called ERI\_TCP and by an increase in the dose of radiotherapy in the final concomitant boost of preoperative radi…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New proton therapy spares spine growth in kids with brain cancer
Disease control Not yet recruitinghis is a single-center, prospective observational study in children and adolescents with central nervous system tumors who need whole-brain and whole-spine radiation therapy (craniospinal irradiation, CSI). The study uses proton therapy with a special vertebral body-sparing (VBS)…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a phone app plus Weight-Loss drugs help people shed pounds and improve heart health?
Disease control Not yet recruitingThis research program includes two coordinated prospective studies (FLOURISH and THRIVE) evaluating the real-world effectiveness of Noom's digital health programs on weight, cardiometabolic biomarkers, physiological health indicators, and program engagement. FLOURISH is a 6-arm …
Sponsor: Noom Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC